Teva Pharmaceutical diligenceLtd.( NYSE and TASE TEVA) blazoned moment that it’ll issue a press release on its third quarter 2022 fiscal results on Thursday, November 3, 2022 at 700a.m. ET. Following the release, Teva will conduct a conference call and live webcast on the same day, at 800a.m. ET.
In order to share, please register in advance then to gain a original or risk-free phone number and your particular leg.
A live webcast of the call will be available on Teva’s website at http//ir.tevapharm.com/.
Following the conclusion of the call, a renewal of the webcast will be available within 24 hours on Teva’s website.
Teva Pharmaceutical diligenceLtd.( NYSE and TASE TEVA) has been developing and producing drugs to ameliorate people’s lives for further than a century. We’re a global leader in general and specialty drugs with a portfolio conforming of over,500 products in nearly every remedial area. Around 200 million people around the world take a Teva drug every day, and are served by one of the largest and most complex force chains in the pharmaceutical assiduity. Along with our established presence in generics, we’ve significant innovative exploration and operations supporting our growing portfolio of specialty and biopharmaceutical products.
Source link: https://www.tevapharm.com/